Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/19147757

Clin. Cancer Res. 2009 Jan 15 15 2 520-31

Download in:

View as

General Info

PMID
19147757